Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'antiarrhythmia agents' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 79 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Takenaka, K; Yasuda, S; Miyazaki, S; Kurita, T; Sutani, Y; Morii, I; Daikoku, S; Kamakura, S; Nonogi, H
      Initial experience with nifekalant hydrochloride (MS-551), a novel class III antiarrhythmic agent, in patients with acute extensive infarction and severe ventricular dysfunction

      JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION
    2. Lu, ZB; Kamiya, K; Opthof, T; Yasui, K; Kodama, I
      Density and kinetics of I-Kr and I-Ks in guinea pig and rabbit ventricularmyocytes explain different efficacy of I-Ks blockade at high heart rate inguinea pig and rabbit - Implications for arrhythmogenesis in humans

      CIRCULATION
    3. Pedersen, OD; Bagger, H; Keller, N; Marchant, B; Kober, L; Torp-Pedersen, C
      Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function - A Danish Investigations of Arrhythmia and Mortality ON Dofetilide (DIAMOND) substudy

      CIRCULATION
    4. van Opstal, JM; Schoenmakers, M; Verduyn, SC; de Groot, SHM; Leunissen, JDM; van der Hulst, FF; Molenschot, MMC; Wellens, HJJ; Vos, MA
      Chronic amiodarone evokes no Torsade de Pointes arrhythmias despite QT lengthening in an animal model of acquired long-QT syndrome

      CIRCULATION
    5. Han, W; Chartier, D; Li, DS; Nattel, S
      Ionic remodeling of cardiac Purkinje cells by congestive heart failure

      CIRCULATION
    6. Glatter, KA; Dorostkar, PC; Yang, YF; Lee, RJ; Van Hare, GF; Keung, E; Modin, G; Scheinman, MM
      Electrophysiological effects of ibutilide in patients with accessory pathways

      CIRCULATION
    7. Simon, T; Mary-Krause, M; Funck-Brentano, C; Jaillon, P
      Sex differences in the prognosis of congestive heart failure - Results from The Cardiac Insufficiency Bisoprolol Study (CIBIS II)

      CIRCULATION
    8. Hondeghem, LM; Carlsson, L; Duker, G
      Instability and triangulation of the action potential predict serious proarrhythmia, but action potential duration prolongation is antiarrhythmic

      CIRCULATION
    9. Brendorp, B; Elming, H; Jun, L; Kober, L; Malik, M; Jensen, GB; Torp-Pedersen, C
      QTc interval as a guide to select those patients with congestive heart failure and reduced left ventricular systolic function who will benefit from antiarrhythmic treatment with dofetilide

      CIRCULATION
    10. Greene, M; Newman, D; Geist, M; Paquette, M; Heng, D; Dorian, P
      Is electrical storm in ICD patients the sign of a dying heart? Outcome of patients with clusters of ventricular tachyarrhythmias

      EUROPACE
    11. Wyndham, CRC
      Atrial fibrillation - The most common arrhythmia

      TEXAS HEART INSTITUTE JOURNAL
    12. Geelen, P; O'Hara, GE; Plante, S; Philippon, F; Gilbert, M; Turgeon, J
      Ischemia-induced action potential shortening is blunted by d-sotalol in a pig model of reversible myocardial ischemia

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    13. Chaudhry, GM; Haffajee, CI
      Antiarrhythmic agents and proarrhythmia

      CRITICAL CARE MEDICINE
    14. Abriel, H; Wehrens, XHT; Benhorin, J; Kerem, B; Kass, RS
      Molecular pharmacology of the sodium channel mutation D1790G linked to thelong-QT syndrome

      CIRCULATION
    15. Nademanee, K; Taylor, R; Bailey, WE; Rieders, DE; Kosar, EM
      Treating electrical storm - Sympathetic blockade versus advanced cardiac life support-guided therapy

      CIRCULATION
    16. Kuck, KH; Cappato, R; Siebels, J; Ruppel, R
      Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest - The Cardiac Arrest Study Hamburg (CASH)

      CIRCULATION
    17. Mounsey, JP; DiMarco, JP
      Dofetilide

      CIRCULATION
    18. Singh, S; Zoble, RG; Yellen, L; Brodsky, MA; Feld, GK; Berk, M; Billing, CB
      Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter -The Symptomatic Atrial Fibrillation Investigative Research on Dofetilide (SAFIRE-D) study

      CIRCULATION
    19. Cabo, C; Schmitt, H; Wit, AL
      New mechanism of antiarrhythmic drug action - Increasing L-type calcium current prevents reentrant ventricular tachycardia in the infarcted canine heart

      CIRCULATION
    20. Brugada, R; Brugada, J; Antzelevitch, C; Kirsch, GE; Potenza, D; Towbin, JA; Brugada, P
      Sodium channel blockers identify risk for sudden death in patients with ST-Segment elevation and right bundle branch block but structurally normal hearts

      CIRCULATION
    21. Rouet, R; Picard, S; Libersa, C; Ghadanfar, M; Alabaster, C; Gerard, JL
      Electrophysiological effects of dofetilide in an in vitro model of "borderzone" between normal and ischemic/reperfused myocardium

      CIRCULATION
    22. Galante, A; Pietroiusti, A; Cavazzini, C; Magrini, A; Bergamaschi, A; Sciarra, L; Chartouni, G; Legramante, JM; Carta, S
      Incidence and risk factors associated with cardiac arrhythmias during rehabilitation after coronary artery bypass surgery

      ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION
    23. O'Callaghan, PA; Camm, AJ
      Treatment of arrhythmias in heart failure

      EUROPEAN JOURNAL OF HEART FAILURE
    24. Friedman, HS; Rodney, E; Sinha, B; Sharafkhaneh, A; Watanasuwan, N; Win, M; Mallipeddi, D; Sinha, A; Hussain, A; Dai, CP
      Verapamil prolongs atrial fibrillation by evoking an intense sympathetic neurohumoral effect

      JOURNAL OF INVESTIGATIVE MEDICINE
    25. Davis, DR; Beatch, GN; Dickenson, DR; Tang, ASL
      Dofetilide enhances shock-induced extension of refractoriness and lowers defibrillation threshold

      CANADIAN JOURNAL OF CARDIOLOGY
    26. Alings, M; Wilde, A
      "Brugada" syndrome - Clinical data and suggested pathophysiological mechanism

      CIRCULATION
    27. Fromm, MF; Kim, RB; Stein, CM; Wilkinson, GR; Roden, DM
      Inhibition of P-glycoprotein-mediated drug transport - A unifying mechanism to explain the interaction between digoxin and quinidine

      CIRCULATION
    28. Levy, S; Maarek, M; Coumel, P; Guize, L; Lekieffre, J; Medvedowsky, JL; Sebaoun, A
      Characterization of different subsets of atrial fibrillation in general practice in France - The ALFA study

      CIRCULATION
    29. Murgatroyd, FD; Gibson, SM; Xie, BY; O'Nunain, S; Poloniecki, JD; Ward, DE; Malik, M; Camm, AJ
      Double-blind placebo-controlled trial of digoxin in symptomatic paroxysmalatrial fibrillation

      CIRCULATION
    30. Boutitie, F; Boissel, JP; Connolly, SJ; Camm, AJ; Cairns, JA; Julian, DG; Gent, M; Janse, NJ; Dorian, P; Frangin, G
      Amiodarone interaction with beta-blockers - Analysis of the merged EMIAT (European Myocardial Infarct Amiodarone Trial) and CAMIAT (Canadian Amiodarone Myocardial Infarction Trial) databases

      CIRCULATION
    31. Anderson, JL; Hallstrom, AP; Epstein, AE; Pinski, SL; Rosenberg, Y; Nora, MO; Chilson, D; Cannom, DS; Moore, R
      Design and results of the Antiarrhythmics Vs Implantable Defibrillators (AVID) Registry

      CIRCULATION
    32. Marshall, HJ; Harris, ZI; Griffith, MJ; Holder, RL; Gammage, MD
      Prospective randomized study of ablation and pacing versus medical therapyfor paroxysmal atrial fibrillation - Effects of pacing mode and mode-switch algorithm

      CIRCULATION
    33. Ide, T; Tsutsui, H; Kinugawa, S; Utsumi, H; Takeshita, A
      Amiodarone protects cardiac myocytes against oxidative injury by its free radical scavenging action

      CIRCULATION
    34. VanderLugt, JT; Mattioni, T; Denker, S; Torchiana, D; Ahern, T; Wakefield, LK; Perry, KT; Kowey, PR
      Efficacy and safety of ibutilide fumarate for the conversion of atrial arrhythmias after cardiac surgery

      CIRCULATION
    35. Bauer, A; Becker, R; Freigang, KD; Senges, JC; Voss, F; Hansen, A; Muller, M; Lang, HJ; Gerlach, U; Busch, A; Kraft, P; Kubler, W; Schols, W
      Rate- and site-dependent effects of propafenone, dofetilide and the new I-Ks-blocking agent chromanol 293b on individual muscle layers of the intact canine heart

      CIRCULATION
    36. Fareh, S; Benardeau, A; Thibault, B; Nattel, S
      The T-Type Ca2+ channel blocker mibefradil prevents the development of a substrate for atrial fibrillation by tachycardia-induced atrial remodeling in dogs

      CIRCULATION
    37. Lynch, JJ; Houle, MS; Stump, GL; Wallace, AA; Gilberto, DB; Jahansouz, H; Smith, GR; Tebben, AJ; Liverton, NJ; Selnick, HG; Claremon, DA; Billman, GE
      Antiarrhythmic efficacy of selective blockade of the cardiac slowly activating delayed rectifier current, I-Ks, in canine models of malignant ischemic ventricular arrhythmia

      CIRCULATION
    38. Kim, YH; Xie, FG; Yashima, M; Wu, TJ; Valderrabano, M; Lee, MH; Ohara, T; Voroshilovsky, O; Doshi, RN; Fishbein, MC; Qu, ZL; Garfinkel, A; Weiss, JN; Karagueuzian, HS; Chen, PS
      Role of papillary muscle in the generation and maintenance of reentry during ventricular tachycardia and fibrillation in isolated swine right ventricle

      CIRCULATION
    39. Li, DS; Fareh, S; Leung, TK; Nattel, S
      Promotion of atrial fibrillation by heart failure in dogs - Atrial remodeling of a different sort

      CIRCULATION
    40. Lacroix, D; Extramiana, F; Delfaut, P; Adamantidis, M; Grandmougin, D; Klug, D; Kacet, S; Dupuis, B
      Factors affecting epicardial dispersion of repolarization: a mapping studyin the isolated porcine heart

      CARDIOVASCULAR RESEARCH
    41. PRITCHETT ELC
      EVOLUTION AND REVOLUTION IN DRUG LABELING - REGULATION OF ANTIARRHYTHMIC DRUGS BY THE FOOD-AND-DRUG-ADMINISTRATION 1962-1996

      PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY
    42. YU WC; CHEN SA; TAI CT; WEN ZC; FENG AN; DING YA; CHANG MS
      EFFECTS OF PROCAINAMIDE AND DL-SOTALOL ON THE CHANGES OF ATRIAL ELECTROPHYSIOLOGY INDUCED BY HIGH-CURRENT STIMULATION

      PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY
    43. YU WC; CHEN SA; LEE SH; TAI CT; FENG AN; KUO BIT; DING YA; CHANG MS
      TACHYCARDIA-INDUCED CHANGE OF ATRIAL REFRACTORY PERIOD IN HUMANS - RATE DEPENDENCY AND EFFECTS OF ANTIARRHYTHMIC DRUGS

      Circulation
    44. TAI CT; CHEN SA; FENG AN; YU WC; CHEN YJ; CHANG MS
      ELECTROPHARMACOLOGIC EFFECTS OF CLASS-I AND CLASS-III ANTIARRHYTHMIA DRUGS ON TYPICAL ATRIAL-FLUTTER - INSIGHTS INTO THE MECHANISM OF TERMINATION

      Circulation
    45. MYERBURG RJ; MITRANI R; INTERIAN A; CASTELLANOS A
      INTERPRETATION OF OUTCOMES OF ANTIARRHYTHMIC CLINICAL-TRIALS - DESIGN-FEATURES AND POPULATION-IMPACT

      Circulation
    46. ABDULLA R; YOUNG S; BARNES SD
      THE PEDIATRIC CARDIOLOGY PHARMACOPEIA

      Pediatric cardiology
    47. DONGER C; DENJOY I; BERTHET M; NEYROUD N; CRUAUD C; BENNACEUR M; CHIVORET G; SCHWARTZ K; COUMEL P; GUICHENEY P
      KVLQT1 C-TERMINAL MISSENSE MUTATION CAUSES A FORME-FRUSTE LONG-QT SYNDROME

      Circulation
    48. SIM I; MCDONALD KM; LAVORI PW; NORBUTAS CM; HLATKY MA
      QUANTITATIVE OVERVIEW OF RANDOMIZED TRIALS OF AMIODARONE TO PREVENT SUDDEN CARDIAC DEATH

      Circulation
    49. BRIGNOLE M; GIANFRANCHI L; MENOZZI C; ALBONI P; MUSSO G; BONGIORNI MG; GASPARINI M; RAVIELE A; LOLLI G; PAPARELLA N; ACQUARONE S
      ASSESSMENT OF ATRIOVENTRICULAR JUNCTION ABLATION AND DDDR MODE-SWITCHING PACEMAKER VERSUS PHARMACOLOGICAL TREATMENT IN PATIENTS WITH SEVERELY SYMPTOMATIC PAROXYSMAL ATRIAL-FIBRILLATION - A RANDOMIZED CONTROLLED-STUDY

      Circulation
    50. KOREN MJ; BUDA C; HENRY W; ELLISON WT; MILAS JM; MORGAN M; SPRINKLE L; MCGREEVY MJ; GOLDBERG RK; GERRY S; BARRETT M; CONNOLLY S; MORRISON L; ABRAHAMSON DC; SOMOGYI C; WEISS RJ; ABISALIH DN; RIDLEY C; BROWNE KF; MCGOWAN N; HARIMAN RJ; TULLY M; BISSETT J; MAY R; HEYWOOD JT; FABBRI S; CRAWFORD W; PLATT M; BRAMLET D; MORGAN C; DILLON MC; ROARK S; MARQUIS N; PAGE RL; CANBY RC; HORTON RP; ASH G; SHETTIGAR UR; BARBIER G; APPUNN D; LEONELLI F; MCFARLAND T; RAJKOVICH K; PRITCHETT ELC; TORMEY MA; WALKER JL; CARLEY JE; TRACY DM; ANDERSON JL; KARAGOUNIS LA; SUMMERS K; BARKER AH; FOWLES RE; PREECE MJ; DORAN EN; ROY D; TALAJIC M; DUBUC M; BEAUDOIN D; FUJIMURA O; ACERON D; ONUFER J; BARCIANO R; CAMERON D; WELLER B; DREHOBL M; BRODKIN J; JOSWIG B; BARKER M; SCHU D; KREMERS MS; WHISNANT D; LURIE M; BRINKLEY A; POLLAK SJ; NICHOLLS S; BLOOMFIELD D; DESTEFANO M; KING N; GERIS B; GREEN M; TANG ASL; LUCE M; ELSHAHAWY M; WAGNER M; RUDGE J; STEINBERG JS; TAN E; YEE R; KLEIN GJ; BRANEY M; BACKES R; MILLER K; BRANCO M; MYERS D; SUGGS T; SHAH A; HEUS B; TRIZZINO C; GROSSMAN WJ; FLETCHER K; LOH IK; SMITH C; DEGENNARO K; SINGER I; CICIC A; LANGAN MN; GOMES JA; MEHTA D; PE E; SAGER PT; PLOSS D; ATTIN M; LUEKEN M; GRAY RJ; CHELLIAH NN; HAGEN K; CARTER D; GRAY C; CURTIS AB; CONTI JB; SALVETTI L; SHELDON R; RITCHIE D; ELLENBOGEN K; WOOD MA; MICHAELS N; HALL JH; FAUSSET D; LINDEN P; SCHULMAN C; GERSHENGORN K; SALTZ S; KINSMAN E; JACOBSON K; LITTELL F; MOSSBERG J; DAUW K; KARLSBERG RP; GEREZ T; TOBIS FM; RASMUSSEN E; CARLSON M; WALKER B; SILVERMAN B; BANASIK S; RUBIN M; BUSCH J; HACK TC; CRIASIA M; FLOREK R; HAMLIN M; FRIEDMAN J; DINNING A; MISALJEVIC Y; KELLER M; TRAJILLO N; ANDERSON D; WAGSHAL A; ROFINO K; MOTTA M; BLOCK LS; WISTRAN DC; GROGAN EW; SOMMERFELDT B; ROTHROCK D; BARON S; STEDFIELD S; SWENSON L; GILBERT B; BERNSTEIN V; KERR C; MACDONALD K; MOONEY S; BILSKER MS; KAMERMAN M; BRADLEY J; PEACOCK T; CHEN PS; GOODMAN JS; PETER CT; SCHOENBAUM M; CONTE S; CURLEE P; BOOKER R; DICARLO LA; KAPPLER JH; WINSTON SA; ADOLPHSON M; HENTHORN R; LIPPS J; IBANEZ K; JOHNSON WB; POLICH M; MARTIN DT; WOODHEAD G; MOORE SL; MISHAK S; MANHOLT S; NOLL HE; KELLEY JG; PERLMAN R; GUIDO J; STAMBLER B; SARGENT D; STEIN J; WILLIS R; STOEVER WW; COTHAM P; MASON K; GABER J; WINTERS SL; CURWIN JH; BANAS JS; ENRIGHT LJ; BRODSKY M; CHAIM S; CARLSON H; FURKA E; DAUBERT J; AKIYAMA T; FLYNN D; OCAMPO C; ERDIN RA; HEIGES TA; KADEL K; STUCKY ED; RITTENHOUSE M; MCANULTY J; TIMBERG J; MCNEER JF; SMITH B; MURRAY KT; NORRIS K; EDGETT C; SORENSON JL; ADELMAN B; STONER D; OFFENBERG H; ARNOW L; THIND G; FAUGHN C; WILLIAMS D; HENDRICKS E; FRIEDMAN B; PAYNE W; FUENZALIDA CE; WASHAM M; HEINSIMER J; LENTINI MG; WEINBERG DM; FOX C; MCCOWN R; COOK FS; ODONOGHUE S; FENTON J; CHUNG M; KIDWELL GA; JAEGER FJ; HOLMES DR; MORANT VA; TROHMAN RG; WILKOFF BL; PINSKI SL; TCHOU PJ; HOLMES D; KERIN NZ; FAITEL K; STAMATO NJ; WHITING D; BHALLA RK; HICKS T; BIANCHI P; HAMILTON W; CHILSON D; BAXTER J; CONTRAFATTO DS; AFSHARI D; GUARNIERI T; BOLDERMAN K; MARGOLIS PD; DURHAM J; MARTIN HM; WAYAND CE; MCGREW F; WILSON B; NADEMANEE K; SMITH S; SHARMA A; ONEILL G; SKADSEN A; WARE D; MALMBERG G; WILSON M; BEDNARCZYK E; BATESON M; ZINN PD; ROBLES E; CULLORS D; CROSSLEY G; DAVISOBRIEN K; FRISHMAN WH; ROOT L; BLANCO B; FURIA S; GOODMAN L; JONESLANIER S; KOCHERIL A; WINECOFF A; PACKER D; COSBERG K; BARBEY JT; HEWETTMEULMAN J; WERTHEIMER J; FIERSTEIN J; BENENE C; HURWITZ J; ALEXANDER L; WIMBERLY B; OVERWEG N; MEJIA V; PACIFICO A; FARRELL M; STEINMAN R; VALMEJIAS J; PATTERSON P; WILSON J; ENRIGHT L; DYCKMAN E; HARRIS B; RAINES P; PAUL T; BLACKMAN T; PORTERFIELD JG; PORTERFIELD LM; ROTH J; VAGNONI J
      TREATMENT OF ATRIAL-FIBRILLATION AND PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA WITH BIDISOMIDE

      Circulation
    51. CARUSO AC; MARCUS FI; HAHN EA; HARTZ VL; MASON JW
      PREDICTORS OF ARRHYTHMIC DEATH AND CARDIAC-ARREST IN THE ESVEM TRIAL

      Circulation
    52. HAMADA M; SHIGEMATSU Y; IKEDA S; HARA Y; OKAYAMA H; KODAMA K; OCHI T; HIWADA K
      CLASS IA ANTIARRHYTHMIC DRUG CIBENZOLINE - A NEW APPROACH TO THE MEDICAL-TREATMENT OF HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY

      Circulation
    53. STAMBLER BS; WOOD MA; ELLENBOGEN KA
      ANTIARRHYTHMIC ACTIONS OF INTRAVENOUS IBUTILIDE COMPARED WITH PROCAINAMIDE DURING HUMAN ATRIAL-FLUTTER AND FIBRILLATION - ELECTROPHYSIOLOGICAL DETERMINANTS OF ENHANCED CONVERSION EFFICACY

      Circulation
    54. BOUABBOUD E; NATTEL S
      RELATIVE ROLE OF ALKALOSIS AND SODIUM-IONS IN REVERSAL OF CLASS-I ANTIARRHYTHMIC DRUG-INDUCED SODIUM-CHANNEL BLOCKADE BY SODIUM-BICARBONATE

      Circulation
    55. DEMOLIS JL; FUNCKBRENTANO C; ROPERS J; GHADANFAR M; NICHOLS DJ; JAILLON P
      INFLUENCE OF DOFETILIDE ON QT-INTERVAL DURATION AND DISPERSION AT VARIOUS HEART-RATES DURING EXERCISE IN HUMANS

      Circulation
    56. STAMBLER BS; WOOD MA; ELLENBOGEN KA; PERRY KT; WAKEFIELD LK; VANDERLUGT JT; ABISAMRA FM; AHERN TS; BURGER AJ; CASSIDY DM; DENKER ST; DIMARCO JP; FLOWERS NC; SRIDHARAN R; HESSEN SH; KALBFLEISCH JM; KOWEY PR; MATTIONI TA; MEISSNER MD; PORTNOW AS; STRATTON SS; SAGER PT; SHARMA AD; WESLEY RC; WINDLE JR; ZOBLE RG
      EFFICACY AND SAFETY OF REPEATED INTRAVENOUS DOSES OF IBUTILIDE FOR RAPID CONVERSION OF ATRIAL-FLUTTER OR FIBRILLATION

      Circulation
    57. VALENZUELA C; DELPON E; FRANQUEZA L; GAY P; PEREZ O; TAMARGO J; SNYDERS DJ
      CLASS-III ANTIARRHYTHMIC EFFECTS OF ZATEBRADINE - TIME-DEPENDENT, STATE-DEPENDENT, USE-DEPENDENT, AND VOLTAGE-DEPENDENT BLOCK OF HKV1.5 CHANNELS

      Circulation
    58. JURKIEWICZ NK; WANG JX; FERMINI B; SANGUINETTI MC; SALATA JJ
      MECHANISM OF ACTION-POTENTIAL PROLONGATION BY RP-58866 AND ITS ACTIVEENANTIOMER, TERIKALANT - BLOCK OF THE RAPIDLY ACTIVATING DELAYED RECTIFIER K-KR( CURRENT, I)

      Circulation
    59. LEHMANN MH; HARDY S; ARCHIBALD D; QUART B; MACNEIL DJ
      SEX DIFFERENCE IN RISK OF TORSADE-DE-POINTES WITH D,L-SOTALOL

      Circulation
    60. DENNIS DM; RAATIKAINEN P; MARTENS JR; BELARDINELLI L
      MODULATION OF ATRIOVENTRICULAR NODAL FUNCTION BY METABOLIC AND ALLOSTERIC REGULATORS OF ENDOGENOUS ADENOSINE IN GUINEA-PIG HEART

      Circulation
    61. OLSCHEWSKI A; BRAU ME; OLSCHEWSKI H; HEMPELMANN G; VOGEL W
      ATP-DEPENDENT POTASSIUM CHANNEL IN RAT CARDIOMYOCYTES IS BLOCKED BY LIDOCAINE - POSSIBLE IMPACT ON THE ANTIARRHYTHMIC ACTION OF LIDOCAINE

      Circulation
    62. SNYDERS DJ; YEOLA SW
      DETERMINANTS OF ANTIARRHYTHMIC DRUG-ACTION - ELECTROSTATIC AND HYDROPHOBIC COMPONENTS OF BLOCK OF THE HUMAN CARDIAC HKV1.5 CHANNEL

      Circulation research
    63. COBBE SM; RAE AP; POLONIECKI JD; CHONG E; BALNAVE K; MORIARTY A; BLACKWOOD R; CAHILL N; COBBE S; PYE M; SEDGWICK M; COOPER D; FLINT J; GOULD B; HUTCHISON S; IRVINE N; LEWIS P; OKEEFE B; SANDERSON J; RAE A; LIP G; GEMMILL J; SHIU G; SILAS J; WATKINS J; STEPHENS J
      A RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF PROPAFENONE IN THE PROPHYLAXIS OF PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA AND PAROXYSMAL ATRIAL-FIBRILLATION

      Circulation
    64. HOHNLOSER SH; MEINERTZ T; STUBBS P; CRIJNS HJGM; BLANC JJ; RIZZON P; CHEUVART B
      EFFICACY AND SAFETY OF D-SOTALOL, A PURE CLASS-III ANTIARRHYTHMIC COMPOUND, IN PATIENTS WITH SYMPTOMATIC COMPLEX VENTRICULAR ECTOPY - RESULTS OF A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED DOSE-FINDING STUDY

      Circulation
    65. UJHELYI MR; SCHUR M; FREDE T; GABEL M; MARKEL ML
      DIFFERENTIAL-EFFECTS OF LIDOCAINE ON DEFIBRILLATION THRESHOLD WITH MONOPHASIC VERSUS BIPHASIC SHOCK WAVE-FORMS

      Circulation
    66. RANGER S; NATTEL S
      DETERMINANTS AND MECHANISMS OF FLECAINIDE-INDUCED PROMOTION OF VENTRICULAR-TACHYCARDIA IN ANESTHETIZED DOGS

      Circulation
    67. VALENZUELA C; SNYDERS DJ; BENNETT PB; TAMARGO J; HONDEGHEM LM
      STEREOSELECTIVE BLOCK OF CARDIAC SODIUM-CHANNELS BY BUPIVACAINE IN GUINEA-PIG VENTRICULAR MYOCYTES

      Circulation
    68. ZIPES DP
      ARE IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS BETTER THAN CONVENTIONAL ANTIARRHYTHMIC DRUGS FOR SURVIVORS OF CARDIAC-ARREST

      Circulation
    69. WEVER EFD; HAUER RNW; VANCAPELLE FJL; TIJSSEN JGP; CRIJNS HJGM; ALGRA A; WIESFELD ACP; BAKKER PFA; DEMEDINA EOR
      RANDOMIZED STUDY OF IMPLANTABLE DEFIBRILLATOR AS FIRST-CHOICE THERAPYVERSUS CONVENTIONAL STRATEGY IN POSTINFARCT SUDDEN-DEATH SURVIVORS

      Circulation
    70. SAKSENA S; EPSTEIN AE; LAZZARA R; MALONEY JD; ZIPES DP; BENDITT DG; CAMM AJ; DOMANSKI MJ; FISHER JD; GERSH BJ; LAMAS GA; LEHMANN MH; NICKELSON DE; PRYSTOWSKY EN; WYSE G
      CLINICAL INVESTIGATION OF ANTIARRHYTHMIC DEVICES - A STATEMENT FOR HEALTH-CARE PROFESSIONALS FROM A JOINT TASK-FORCE OF THE AMERICAN-HEART-ASSOCIATION, THE -AMERICAN-SOCIETY-OF-PACING-AND-ELECTROPHYSIOLOGY, THE AMERICAN-COLLEGE-OF-CARDIOLOGY, AND THE WORKING GROUPS ON ARRHYTHMIAS AND CARDIAC PACING OF THE EUROPEAN-SOCIETY-OF-CARDIOLOGY - BASED ON PROCEEDINGS OF THE POLICY CONFERENCE HELD NOVEMBER 15-16, 1993, WASHINGTON, DC

      Circulation
    71. RESTIVO M; YIN H; CAREF EB; PATEL AI; NDREPEPA G; AVITABLE MJ; ASSADI MA; ISBER N; ELSHERIF N
      REENTRANT ARRHYTHMIAS IN THE SUBACUTE INFARCTION PERIOD - THE PROARRHYTHMIC EFFECT OF FLECAINIDE ACETATE ON FUNCTIONAL REENTRANT CIRCUITS

      Circulation
    72. GROH WJ; GIBSON KJ; MCANULTY JH; MAYLIE JG
      BETA-ADRENERGIC BLOCKING PROPERTY OF DL-SOTALOL MAINTAINS CLASS-III EFFICACY IN GUINEA-PIG VENTRICULAR MUSCLE AFTER ISOPROTERENOL

      Circulation
    73. MORI K; HARA Y; SAITO T; MASUDA Y; NAKAYA H
      ANTICHOLINERGIC EFFECTS OF CLASS-III ANTIARRHYTHMIC DRUGS IN GUINEA-PIG ATRIAL CELLS - DIFFERENT MOLECULAR MECHANISMS

      Circulation
    74. GOLDSTEIN S; BROOKS MM; LEDINGHAM R; KENNEDY HL; EPSTEIN AE; PAWITAN Y; BIGGER JT
      ASSOCIATION BETWEEN EASE OF SUPPRESSION OF VENTRICULAR ARRHYTHMIA ANDSURVIVAL

      Circulation
    75. SIDDOWAY LA
      SPECIAL CONSIDERATIONS FOR THE USE OF ANTIARRHYTHMIC MEDICATION IN ANAGING POPULATION

      Cardiology in the elderly
    76. ARVEUX I; PFITZENMEYER P; COTTIN Y; GAUDET M
      ARRHYTHMIA IN THE ELDERLY - CURRENT THERA PEUTIC APPROACH

      La Semaine des hopitaux de Paris
    77. HAUGLAND FN; JOHNSON SB; PACKER DL
      DIRECT QUANTIFICATION OF APPARENT BINDING INDEXES FROM QUINIDINE-INDUCED IN-VIVO CONDUCTION DELAY IN CANINE MYOCARDIUM

      The Journal of clinical investigation
    78. WINDLE JR; WITT RC; ROZANSKI GJ
      EFFECTS OF FLECAINIDE ON ECTOPIC ATRIAL AUTOMATICITY AND CONDUCTION

      Circulation
    79. WANG JJ; BOURNE GW; WANG ZG; VILLEMAIRE C; TALAJIC M; NATTEL S
      COMPARATIVE MECHANISMS OF ANTIARRHYTHMIC DRUG-ACTION IN EXPERIMENTAL ATRIAL-FIBRILLATION - IMPORTANCE OF USE-DEPENDENT EFFECTS ON REFRACTORINESS

      Circulation


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 16/01/21 alle ore 20:04:35